BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 21538440)

  • 1. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
    Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
    El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
    Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
    Petrick JL; Yang B; Altekruse SF; Van Dyke AL; Koshiol J; Graubard BI; McGlynn KA
    PLoS One; 2017; 12(10):e0186643. PubMed ID: 29049401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
    Shaib YH; El-Serag HB; Davila JA; Morgan R; McGlynn KA
    Gastroenterology; 2005 Mar; 128(3):620-6. PubMed ID: 15765398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
    Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.
    Davila JA; Morgan RO; Shaib Y; McGlynn KA; El-Serag HB
    Gut; 2005 Apr; 54(4):533-9. PubMed ID: 15753540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of primary and secondary liver cancers].
    Jepsen P; Kissmeyer-Nielsen P
    Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.
    Petrick JL; Freedman ND; Graubard BI; Sahasrabuddhe VV; Lai GY; Alavanja MC; Beane-Freeman LE; Boggs DA; Buring JE; Chan AT; Chong DQ; Fuchs CS; Gapstur SM; Gaziano JM; Giovannucci EL; Hollenbeck AR; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Schairer C; Sesso HD; Sigurdson AJ; Zeleniuch-Jacquotte A; Wactawski-Wende J; Campbell PT; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1398-406. PubMed ID: 26126626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
    PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in primary liver cancer in the UK, 1979-94.
    Taylor-Robinson SD; Foster GR; Arora S; Hargreaves S; Thomas HC
    Lancet; 1997 Oct; 350(9085):1142-3. PubMed ID: 9343506
    [No Abstract]   [Full Text] [Related]  

  • 12. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
    Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
    McGlynn KA; Tarone RE; El-Serag HB
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Have incidence rates of liver cancer peaked in the United States?
    Petrick JL; Florio AA; Loomba R; McGlynn KA
    Cancer; 2020 Jul; 126(13):3151-3155. PubMed ID: 32294255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Welzel TM; Graubard BI; Quraishi S; Zeuzem S; Davila JA; El-Serag HB; McGlynn KA
    Am J Gastroenterol; 2013 Aug; 108(8):1314-21. PubMed ID: 23752878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.
    Makarova-Rusher OV; Altekruse SF; McNeel TS; Ulahannan S; Duffy AG; Graubard BI; Greten TF; McGlynn KA
    Cancer; 2016 Jun; 122(11):1757-65. PubMed ID: 26998818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma.
    Lee CH; Chang CJ; Lin YJ; Yeh CN; Chen MF; Hsieh SY
    Br J Cancer; 2009 Jun; 100(11):1765-70. PubMed ID: 19436294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.